Travere Therapeutics Profit Margin 2012-2021 | TVTX
Current and historical gross margin, operating margin and net profit margin for Travere Therapeutics (TVTX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Travere Therapeutics net profit margin as of June 30, 2021 is -116.12%.
|Travere Therapeutics Annual Profit Margins
|Travere Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.